Serological abnormalities in bird fancier's lung: Author's reply

par Udwadia, Zarir F
Publié 1990

Disseminated tuberculosis with immune thrombocytopenic purpura

par Dagaonkar, Rucha S., Udwadia, Zarir F.
Publié 2012

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai

par Udwadia, Zarir F., Moharil, Gautam
Publié dans Lung India (2014)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?

par Pinto, Lancelot M, Udwadia, Zarir F
Publié 2010

How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus

par Udwadia, Zarir F., Raju, Reyma Sara
Publié dans Med J Armed Forces India (2020)

The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic

par Udwadia, Zarir F., Raju, Reyma Sara
Publié dans Lung India (2020)

Oxaliplatin-induced lung fibrosis

par Shah, Arpan, Udwadia, Zarir F., Almel, Sachin
Publié 2009

Favipiravir: A new and emerging antiviral option in COVID-19

par Agrawal, Umang, Raju, Reyma, Udwadia, Zarir F.
Publié dans Med J Armed Forces India (2020)

Post-COVID lung fibrosis: The tsunami that will follow the earthquake

par Udwadia, Zarir F, Koul, Parvaiz A, Richeldi, Luca
Publié dans Lung India (2021)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?

par Udwadia, Zarir F., Pinto, Lancelot M., Uplekar, Mukund W.
Publié 2010

Tropical pulmonary eosinophilia - A review

par Mullerpattan, Jai B., Udwadia, Zarir F., Udwadia, Farokh E.
Publié 2013

Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us

par Intini, Enrica, Kishore, Girija, Richeldi, Luca, Udwadia, Zarir F
Publié dans BMJ Case Rep (2019)

Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia

par Sarkar, Trina, Riccardi, Niccolò, Wagh, Haresh, Udwadia, Zarir F
Publié dans Lung India (2020)

Primary immune deficiency in the intensive care unit: It is never too late to diagnose and treat

par Dagaonkar, Rucha S., Sen, Tiyas, Udwadia, Zarir F., Desai, Mukesh B.
Publié 2011

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis

par Udwadia, Zarir F., Mullerpattan, Jai B., Balakrishnan, Canchi, Richeldi, Luca
Publié dans Lung India (2015)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai

par Udwadia, Zarir F, Mullerpattan, Jai Bharat, Shah, Kushal D, Rodrigues, Camilla S
Publié dans Lung India (2016)

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic

par Udwadia, Zarir F., Sharma, Samridhi, Mullerpattan, Jai B., Gajjar, Ishita, Pinto, Lancelot
Publié dans Lung India (2021)

Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China

par Richeldi, Luca, Rubin, Adalberto Sperb, Avdeev, Sergey, Udwadia, Zarir F., Xu, Zuo Jun
Publié dans BMC Med (2015)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic

par Udwadia, Zarir F., Tornheim, Jeffrey A., Ganatra, Shashank, DeLuca, Andrea, Rodrigues, Camilla S., Gupta, Amita
Publié dans BMC Infect Dis (2019)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience

par Mullerpattan, Jai B, Porwal, Sana H, Sarkar, Trina A, Wagh, Haresh D, Udwadia, Zarir F
Publié dans Lung India (2019)